PatientsLikeMe : Bethanechol Treatment Report

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.

Patients

Taking Bethanechol
14 Patients currently take Bethanechol
3 Patients stopped taking Bethanechol
Gypsy Sensation: Severe Overall: Moderate Cognition: moderate Vision: mild Speech: mild Swallowing: mild Upper limb: moderate Walking: moderate See profile Gypsy 50mg daily since Apr 02, 2006
Dianna C Sensation: Moderate Overall: Mild Cognition: moderate Vision: mild Speech: mild Swallowing: mild Upper limb: moderate Walking: moderate See profile Dianna C Urecholine, 75mg daily since Jan 08, 2006

Brand Names: Duvoid, Urecholine
Generic Name: Bethanechol

What is Bethanechol? This is a drug that affects the parasympathetic nervous system. It is used to relieve difficulties in urinating caused by surgery, drugs, or other factors. It stimulates a muscle in the bladder to help you urinate. Read more...

See more information, including instructions, precautions, side effects, and interactions.

Jump to:: Reasons Taken; Dosages; Duration; Patient Evaluations

Reasons Taken

17 patients in the community are taking or have taken Bethanechol.

Reason	# Patients	Percentage of patients
Bladder problems	14	82%
Urinary urgency	1	5%
Other	1	5%

Dosages

Based on the patients currently taking Bethanechol.

20 mg day	25 mg day	50 mg day	75 mg day	100 mg day	125 mg day
3	2	2	3	3	1

Duration

How long current patients have been taking Bethanechol or how long patients were taking Bethanechol before stopping.

Currently taking Bethanechol

0-1 month	1-3 months	3-6 months	6 months-1year	1-2 years	2 years or more
0	0	1	4	2	4

Stopped taking Bethanechol

0-1 month	1-3 months	3-6 months	6 months-1year	1-2 years	2 years or more
1	2	0	0	0	0

Why Patients Stopped Taking Bethanechol (multiple reasons could be selected)
Reason	# Patients	Percentage of patients
Did not seem to work	3	100%
Doctor's advice	2	67%
Side effects too severe	1	33%

Patient Reported Evaluations

Results from 3 patient evaluations. See the overall results and all individual evaluations.

Efficacy (Effect based on reason taken)

Moderate	67%	2
Slight	33%	1

Bladder problems

Side-effects (as an overall problem)

Severe	33%	1
Moderate	0%	0
Mild	0%	0
None	67%	2

Top reported side-effects include: bladder urgency

Summary results are based on 3 individual responses. For more information, see overall results for Adherence, Burden and Cost.

Individual Patient Reported Evaluations (1 of 3)

Gypsy

Sensation: Severe

Overall: Moderate

Cognition: moderate

Vision: mild

Speech: mild

Swallowing: mild

Upper limb: moderate

Walking: moderate

See profile
by Gypsy
Aug 20, 2008